Oral drug avatrombopag reduces chemotherapy treatment delays, trial finds
In a phase 2 trial of patients with gastrointestinal cancers, avatrombopag helped 70% of those receiving chemotherapy to…
Romiplostim shows promise in treating chemotherapy-induced thrombocytopenia
Original story from Mass General Brigham The Phase III RECITE trial has shown that romiplostim prevents serious side…
Romiplostim prevents chemotherapy-induced thrombocytopenia in phase 3 trial
Results from a global phase 3 clinical trial led by investigators at Mass General Brigham show that the…